On Tuesday, Secretary of Defense Pete Hegseth announced that U.S. service members will no longer be required to receive the annual influenza vaccine. In a video statement, he claimed that the flu poses “no threat to our military readiness.”
This assertion contradicts historical evidence. During the 1918 influenza pandemic, more than 20,000 U.S. service members died, and hundreds of thousands were hospitalized. Military personnel of that era suffered some of the highest death rates, which not only devastated troop health but also impacted the U.S. economy and military readiness.
Historians estimate that up to 20% of U.S. service members fell ill during the pandemic. In response, the U.S. military began developing a flu vaccine to ensure future protection for its forces. The decision to drop the mandate raises concerns about preparedness against preventable illnesses.
Related articles
Robert F. Kennedy Jr. Balances Vaccine Skepticism with Ohio Outreach Tour
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most...
Global Health Alert: Ebola and Hantavirus Outbreaks Highlight Gaps in Pandemic Preparedness
The reports emerging this week of a major Ebola outbreak in the Democratic Republic of Congo, coming alongside a growing hantavirus outbreak linked to...
UK Political Shake-Up Could Reshape Global Drug Pricing Policies
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Congrats on...
U.S. Pressures Germany on Drug Prices Amid FDA Restructuring Concerns
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about we...
U.S. Pressures Germany to Increase Payments for Prescription Drugs Amid Trade Tensions
WASHINGTON — Over a recent breakfast, U.S. officials had a message for the German ambassador: pay more for pharmaceuticals. The meeting, between U.S....
PSA Screening Significantly Lowers Prostate Cancer Death Risk, Cochrane Review Confirms
Prostate-specific antigen (PSA) blood testing is likely to reduce the risk of death from prostate cancer, found a new review published on Thursday by...
Dr. Makary's Exit and the Future of Cassidy's Senate Seat: Key Health Policy Shifts
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he...
STAT Unveils 'The Deadliest Drug' Investigation: Alcohol-Related Deaths Surpass 178,000 Annually in the U.S.
Dear Readers, I want to bring your attention to “The Deadliest Drug,” a new STAT investigative series about our nation’s failure to address excessive...